Skip to main content

Stem Cell-Based Therapeutics in Ophthalmology: Application Toward the Design of Clinical Trials

  • Chapter
  • First Online:
Stem Cell Biology and Regenerative Medicine in Ophthalmology

Part of the book series: Stem Cell Biology and Regenerative Medicine ((STEMCELL))

  • 1569 Accesses

Abstract

Stem cell-based therapeutics have been proposed as a technology for restoration of anatomic structure and visual function for retinal degenerative diseases. Success in animal studies and preliminary trials may offer hope for patients afflicted by a variety of retinal degenerations. However, as clinical trials expand and advance to latter phases, it is important to address key study design issues. This chapter discusses the parameters for research into stem cell-based therapeutics. Efficacy endpoints for studies can be defined along objective physiologic, psychofunctional, anatomic, and functional living axes. Pupillometry, electroretinography, and radiologic tools are discussed as objective tools for the assessment of treatment outcome. Additionally, optical coherence tomography(OCT), fundus autofluorescence (FAF), and other imaging tools may be used. Psychofunctional tests may be less reliable among a pediatric population. Finally, improvements in functional living may be reported by patients and assessed by various measures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pellegrini G, Golisano O, Paterna P, Lambiase A, Bonini S, Rama P et al (1999) Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol 145(4):769–82

    Article  PubMed  CAS  Google Scholar 

  2. Dua HS, Azuara-Blanco A (2000) Limbal stem cells of the corneal epithelium. Surv Ophthalmol 44(5):415–25

    Article  PubMed  CAS  Google Scholar 

  3. Nishida K, Yamato M, Hayashida Y, Watanabe K, Yamamoto K, Adachi E et al (2004) Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 351(12):1187–96

    Article  PubMed  CAS  Google Scholar 

  4. Nakamura T, Kinoshita S (2003) Ocular surface reconstruction using cultivated mucosal epithelial stem cells. Cornea 22(7 suppl):S75–80

    Article  PubMed  Google Scholar 

  5. Algvere PV, Gouras P, Dafgard Kopp E (1999) Long-term outcome of RPE allografts in non-immunosuppressed patients with AMD. Eur J Ophthalmol 9(3):217–30

    PubMed  CAS  Google Scholar 

  6. Kaplan HJ, Tezel TH, Berger AS, Del Priore LV (1999) Retinal transplantation. Chem Immunol 73:207–19

    Article  PubMed  CAS  Google Scholar 

  7. Food and Drug Administration Center for Biologics Evaluation and Research. Cellular, Tissue and Gene Therapies Advisory Committee. June 29, 2011. Transcript proceeding by: CASET Associates, Ltd.

    Google Scholar 

  8. Stout JT, Francis PJ (2011) Surgical approaches to gene and stem cell therapy for retinal disease. Hum Gene Ther 22(5):531–5

    Article  PubMed  CAS  Google Scholar 

  9. Bennett J, Ashtari M, Wellman J, Marshall KA, Cycjowski LL, Chung DC et al (2012) AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med 4(120):120ra15

    Article  PubMed  Google Scholar 

  10. Burns ME, Baylor DA (2001) Activation, deactivation, and adaptation in vertebrate photoreceptor cells. Annu Rev Neurosci 24:779–805

    Google Scholar 

  11. Stryer L (1991) Visual excitation and recovery. J Biol Chem 266(17):10711–14

    Google Scholar 

  12. Tsang SH, Gouras P, Yamashita CK, Kjeldbye H, Fisher J, Farber DB et al (1996) Retinal degeneration in mice lacking the gamma subunit of the rod cGMP phosphodiesterase. Science 272(5264):1026–29

    Google Scholar 

  13. Yarfitz S, Hurley JB. Transduction mechanisms of vertebrate and invertebrate photoreceptors. J Biol Chem. 1994;269(20):14329–32.

    PubMed  CAS  Google Scholar 

  14. Arshavsky VY, Lamb TD, Pugh EN, Jr (2002) G proteins and phototransduction. Annu Rev Physiol 64:153–87

    Google Scholar 

  15. Fung BK, Hurley JB, Stryer L (1981) Flow of information in the light-triggered cyclic nucleotide cascade of vision. Pro Natl Acad Sci, USA 78(1):152–6

    Google Scholar 

  16. Lagnado L, Baylor D (1992) Signal flow in visual transduction. Neuron 8(6):995–1002

    Google Scholar 

  17. Tsang SH, Gouras P (1996) Molecular Physiology and Pathology of the Retina. In: Tasman W, Jaeger EA (eds) Duane's Clinical Opthalmology, JB Lippincott, Philadelphia

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rony Gelman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gelman, R., Tsang, S.H. (2013). Stem Cell-Based Therapeutics in Ophthalmology: Application Toward the Design of Clinical Trials. In: Tsang, S. (eds) Stem Cell Biology and Regenerative Medicine in Ophthalmology. Stem Cell Biology and Regenerative Medicine. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-5493-9_11

Download citation

Publish with us

Policies and ethics